Pharma Focus Asia
KP - Sustainable Packaging Solutions

AbCellera Opens New GMP Manufacturing Facility in Canada

Introduction:

AbCellera plans to open Good Manufacturing Practices (GMP) manufacturing facility. The first-of- its-kind facility will be located in Canada.

Features:

The new 130,000-square-foot GMPN facility will be constructed on a current vacant two-acre site. Moreover, this expansion will increase the capabilities of bringing new antibody therapies to clinical trialsand thus supportsquickly to future pandemics.

The new construction will expand capabilities in developing new antibody therapies. Moreover, the planned building will house space for warehousing, GMP protein biologic manufacturing, laboratory and office.

The construction of the facility is scheduled for later this year. It is expected that the new facility will be ready for GMP manufacturing in early 2024.

The manufacturing facility is funded by US$125.6million grant from the Canadian government’s Strategic Innovation Fund (SIF).

The new construction will addhundrends of highly skilled scientific employees to its existing workforce of nearly 300 people in the coming years.

Specifications:

NameAbCellera
TypeNew Construction
Year2024
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelTFS - ODW - The Technology Debate: Single-Use vs. Stainless SteelAsia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 20244th Middle East Pharmacoeconomics and Drug Policy Summit 2024Digital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference
Searching for an end-to-end patient tech solution?